tiprankstipranks
Cigna (CI)
NYSE:CI
US Market
CI
Cigna
RESEARCH TOOLSreports
Want to see CI full AI Analyst Report?

Cigna (CI) Stock Forecast & Price Target

3,614 Followers
See the Price Targets and Ratings of:

CI Analyst Ratings

Strong Buy
18Ratings
Strong Buy
15 Buy
3 Hold
0 Sell
Based on 18 analysts giving stock ratings to
Cigna
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CI Stock 12 Month Forecast

Average Price Target

$343.00
▲(23.10% Upside)
Based on 18 Wall Street analysts offering 12 month price targets for Cigna in the last 3 months. The average price target is $343.00 with a high forecast of $400.00 and a low forecast of $302.00. The average price target represents a 23.10% change from the last price of $278.64.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"240":"$240","401":"$401","280.25":"$280.3","320.5":"$320.5","360.75":"$360.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":400,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$400.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":343,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$343.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":302,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$302.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[240,280.25,320.5,360.75,401],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,282.9,291.9076923076923,300.9153846153846,309.9230769230769,318.9307692307692,327.9384615384615,336.94615384615383,345.95384615384614,354.96153846153845,363.96923076923076,372.9769230769231,381.9846153846154,390.9923076923077,{"y":400,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,282.9,287.5230769230769,292.1461538461538,296.7692307692308,301.39230769230767,306.0153846153846,310.6384615384615,315.26153846153846,319.88461538461536,324.5076923076923,329.1307692307692,333.75384615384615,338.37692307692305,{"y":343,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,282.9,284.36923076923074,285.8384615384615,287.30769230769226,288.7769230769231,290.24615384615385,291.7153846153846,293.18461538461537,294.65384615384613,296.1230769230769,297.5923076923077,299.0615384615385,300.53076923076924,{"y":302,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":328.234,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":308.463,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":329.038,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":258.033,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":296.054,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":288.431,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":241.713,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":270.551,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":273.722,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":270.052,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":289.256,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":267.32,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":282.9,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$400.00Average Price Target$343.00Lowest Price Target$302.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on CI
Lance Wilkes
Bernstein
Bernstein
$371
Buy
33.15%
Upside
Reiterated
05/27/26
Bernstein Keeps Their Buy Rating on Cigna (CI)
Barclays Analyst forecast on CI
Andrew Mok CFA
Barclays
Barclays
$310→$304
Hold
9.10%
Upside
Downgraded
05/26/26
Cigna downgraded to Equal Weight from Overweight at BarclaysCigna downgraded to Equal Weight from Overweight at Barclays
UBS Analyst forecast on CI
A.J. Rice
UBS
UBS
$375→$400
Buy
43.55%
Upside
Assigned
05/22/26
Cigna price target raised to $400 from $375 at UBSCigna price target raised to $400 from $375 at UBS
Morgan Stanley Analyst forecast on CI
Erin Wright
Morgan Stanley
Morgan Stanley
$355→$361
Buy
29.56%
Upside
Assigned
05/21/26
Cigna price target raised to $361 from $355 at Morgan StanleyCigna price target raised to $361 from $355 at Morgan Stanley
Deutsche Bank Analyst forecast on CI
George Hill
Deutsche Bank
Deutsche Bank
$302
Hold
8.38%
Upside
Downgraded
05/20/26
Cigna downgraded to Hold from Buy at Deutsche BankCigna downgraded to Hold from Buy at Deutsche Bank
J.P. Morgan Analyst forecast on CI
Lisa Gill
J.P. Morgan
J.P. Morgan
―
Buy
―
Reiterated
05/15/26
Cigna Earns Buy Rating on Strong Free Cash Flow, Deleveraged Balance Sheet, and Double-Digit EPS Growth Outlook
Bank of America Securities Analyst forecast on CI
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
$378
Buy
35.66%
Upside
Reiterated
05/13/26
Analysts Conflicted on These Healthcare Names: Cardinal Health (NYSE: CAH), Baxter International (NYSE: BAX) and Cigna (NYSE: CI)
Truist Financial Analyst forecast on CI
David S Macdonald
Truist Financial
Truist Financial
$350
Buy
25.61%
Upside
Reiterated
05/05/26
Truist Financial Sticks to Their Buy Rating for Cigna (CI)
TD Cowen Analyst forecast on CI
Charles Rhyee
TD Cowen
TD Cowen
$338
Buy
21.30%
Upside
Assigned
05/04/26
Cigna Maintained at Buy on Specialty Pharmacy Strength and Solid Cost Discipline; $338 Price Target Reaffirmed
Goldman Sachs Analyst forecast on CI
Scott Fidel
Goldman Sachs
Goldman Sachs
$335→$340
Buy
22.02%
Upside
Reiterated
05/03/26
Analysts Offer Insights on Healthcare Companies: Relay Therapeutics (NASDAQ: RLAY), Cigna (NYSE: CI) and Sotera Health (NASDAQ: SHC)
Mizuho Securities Analyst forecast on CI
Ann Hynes
Mizuho Securities
Mizuho Securities
$325→$330
Buy
18.43%
Upside
Reiterated
05/01/26
Cigna price target raised to $330 from $325 at MizuhoCigna price target raised to $330 from $325 at Mizuho
Wells Fargo Analyst forecast on CI
Stephen Baxter
Wells Fargo
Wells Fargo
$300→$305
Hold
9.46%
Upside
Reiterated
05/01/26
Wells Fargo Reaffirms Their Hold Rating on Cigna (CI)
Guggenheim Analyst forecast on CI
Jason Cassorla
Guggenheim
Guggenheim
$334→$338
Buy
21.30%
Upside
Reiterated
05/01/26
Cigna (CI) Receives a Buy from Guggenheim
Robert W. Baird Analyst forecast on CI
Michael Ha
Robert W. Baird
Robert W. Baird
$306→$337
Buy
20.94%
Upside
Reiterated
05/01/26
Cigna price target raised to $337 from $306 at BairdCigna price target raised to $337 from $306 at Baird
Cantor Fitzgerald Analyst forecast on CI
Sarah James
Cantor Fitzgerald
Cantor Fitzgerald
$325→$340
Buy
22.02%
Upside
Reiterated
04/30/26
Cantor Fitzgerald Sticks to Their Buy Rating for Cigna (CI)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on CI
Lance Wilkes
Bernstein
Bernstein
$371
Buy
33.15%
Upside
Reiterated
05/27/26
Bernstein Keeps Their Buy Rating on Cigna (CI)
Barclays Analyst forecast on CI
Andrew Mok CFA
Barclays
Barclays
$310→$304
Hold
9.10%
Upside
Downgraded
05/26/26
Cigna downgraded to Equal Weight from Overweight at BarclaysCigna downgraded to Equal Weight from Overweight at Barclays
UBS Analyst forecast on CI
A.J. Rice
UBS
UBS
$375→$400
Buy
43.55%
Upside
Assigned
05/22/26
Cigna price target raised to $400 from $375 at UBSCigna price target raised to $400 from $375 at UBS
Morgan Stanley Analyst forecast on CI
Erin Wright
Morgan Stanley
Morgan Stanley
$355→$361
Buy
29.56%
Upside
Assigned
05/21/26
Cigna price target raised to $361 from $355 at Morgan StanleyCigna price target raised to $361 from $355 at Morgan Stanley
Deutsche Bank Analyst forecast on CI
George Hill
Deutsche Bank
Deutsche Bank
$302
Hold
8.38%
Upside
Downgraded
05/20/26
Cigna downgraded to Hold from Buy at Deutsche BankCigna downgraded to Hold from Buy at Deutsche Bank
J.P. Morgan Analyst forecast on CI
Lisa Gill
J.P. Morgan
J.P. Morgan
―
Buy
―
Reiterated
05/15/26
Cigna Earns Buy Rating on Strong Free Cash Flow, Deleveraged Balance Sheet, and Double-Digit EPS Growth Outlook
Bank of America Securities Analyst forecast on CI
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
$378
Buy
35.66%
Upside
Reiterated
05/13/26
Analysts Conflicted on These Healthcare Names: Cardinal Health (NYSE: CAH), Baxter International (NYSE: BAX) and Cigna (NYSE: CI)
Truist Financial Analyst forecast on CI
David S Macdonald
Truist Financial
Truist Financial
$350
Buy
25.61%
Upside
Reiterated
05/05/26
Truist Financial Sticks to Their Buy Rating for Cigna (CI)
TD Cowen Analyst forecast on CI
Charles Rhyee
TD Cowen
TD Cowen
$338
Buy
21.30%
Upside
Assigned
05/04/26
Cigna Maintained at Buy on Specialty Pharmacy Strength and Solid Cost Discipline; $338 Price Target Reaffirmed
Goldman Sachs Analyst forecast on CI
Scott Fidel
Goldman Sachs
Goldman Sachs
$335→$340
Buy
22.02%
Upside
Reiterated
05/03/26
Analysts Offer Insights on Healthcare Companies: Relay Therapeutics (NASDAQ: RLAY), Cigna (NYSE: CI) and Sotera Health (NASDAQ: SHC)
Mizuho Securities Analyst forecast on CI
Ann Hynes
Mizuho Securities
Mizuho Securities
$325→$330
Buy
18.43%
Upside
Reiterated
05/01/26
Cigna price target raised to $330 from $325 at MizuhoCigna price target raised to $330 from $325 at Mizuho
Wells Fargo Analyst forecast on CI
Stephen Baxter
Wells Fargo
Wells Fargo
$300→$305
Hold
9.46%
Upside
Reiterated
05/01/26
Wells Fargo Reaffirms Their Hold Rating on Cigna (CI)
Guggenheim Analyst forecast on CI
Jason Cassorla
Guggenheim
Guggenheim
$334→$338
Buy
21.30%
Upside
Reiterated
05/01/26
Cigna (CI) Receives a Buy from Guggenheim
Robert W. Baird Analyst forecast on CI
Michael Ha
Robert W. Baird
Robert W. Baird
$306→$337
Buy
20.94%
Upside
Reiterated
05/01/26
Cigna price target raised to $337 from $306 at BairdCigna price target raised to $337 from $306 at Baird
Cantor Fitzgerald Analyst forecast on CI
Sarah James
Cantor Fitzgerald
Cantor Fitzgerald
$325→$340
Buy
22.02%
Upside
Reiterated
04/30/26
Cantor Fitzgerald Sticks to Their Buy Rating for Cigna (CI)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cigna

3 Months
Ann HynesMizuho Securities
Success Rate
19/29 ratings generated profit
66%
Average Return
+3.81%
Copying Ann Hynes's trades and holding each position for 3 Months would result in 65.52% of your transactions generating a profit, with an average return of +3.81% per trade.
1 Year
Scott FidelGoldman Sachs
Success Rate
23/30 ratings generated profit
77%
Average Return
+17.22%
Copying Scott Fidel's trades and holding each position for 1 Year would result in 76.67% of your transactions generating a profit, with an average return of +17.22% per trade.
2 Years
Scott FidelGoldman Sachs
Success Rate
27/30 ratings generated profit
90%
Average Return
+24.99%
Copying Scott Fidel's trades and holding each position for 2 Years would result in 90.00% of your transactions generating a profit, with an average return of +24.99% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CI Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
14
22
24
28
29
Hold
6
5
6
2
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
20
27
30
30
33
In the current month, CI has received 29 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. CI average Analyst price target in the past 3 months is 343.00.
Each month's total comprises the sum of three months' worth of ratings.

CI Financial Forecast

CI Earnings Forecast

Next quarter’s earnings estimate for CI is $7.55 with a range of $6.99 to $7.73. The previous quarter’s EPS was $7.79. CI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CI has Performed in-line its overall industry.
Next quarter’s earnings estimate for CI is $7.55 with a range of $6.99 to $7.73. The previous quarter’s EPS was $7.79. CI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CI has Performed in-line its overall industry.

CI Sales Forecast

Next quarter’s sales forecast for CI is $70.11B with a range of $68.18B to $72.76B. The previous quarter’s sales results were $68.75B. CI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CI has Performed in-line its overall industry.
Next quarter’s sales forecast for CI is $70.11B with a range of $68.18B to $72.76B. The previous quarter’s sales results were $68.75B. CI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CI has Performed in-line its overall industry.

CI Stock Forecast FAQ

What is CI’s average 12-month price target, according to analysts?
Based on analyst ratings, Cigna’s 12-month average price target is 343.00.
    What is CI’s upside potential, based on the analysts’ average price target?
    Cigna has 23.10% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CI a Buy, Sell or Hold?
          Cigna has a consensus rating of Strong Buy which is based on 15 buy ratings, 3 hold ratings and 0 sell ratings.
            What is Cigna’s price target?
            The average price target for Cigna is 343.00. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $400.00 ,the lowest forecast is $302.00. The average price target represents 23.10% Increase from the current price of $278.64.
              What do analysts say about Cigna?
              Cigna’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.
                How can I buy shares of CI?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.